Cutting Edge Technologies for
Cell- and Molecular Biosciences in the Nordics
Creating value for our customers, suppliers and staff, and ultimately for the public who benefits from scientific discovery.
Creating value for our customers, suppliers and staff, and ultimately for the public who benefits from scientific discovery.
Faster and Easier Flow Cytometry Sample Prep, Synthetic mRNA for Research and Clinical Labs, Next Generation Cell Recovery for Immuno-Oncology etc.
Anti-Müllerian Hormone (AMH) Quality Control, RIQAS Anti-SARS-CoV-2 Serology EQA Programme, Molecular Controls for Infectious Disease etc.
Tapestri Solution for Tumor Profiling in Single Cell, Ultimate Exonic Coverage, Liquid Biopsy Panels etc.
Direct PCR of Crude Samples without Template Purification, highQu PCR & qPCR Reagents Performance Excellence etc.
Electrospray ionization emitters, RAS proteins for oncology research, MagReSyn NTA beads etc.
Genie Purist: Dedicated for Ultrapure (Type I) Water, Operational Reliability and Ease-of-Use etc.
Based on the core technology Ghost Cytometry which enables supervised or unsupervised machine learning-based sorting, ThinkCyte offers the platform VisionSort.
The system provides cellular fingerprints with morphometric readouts in high resolution, on top of standard fluorescence-based sorting.
VisionSort is the perfect addition to conventional cell sorters, by providing unbiased, label-free cell characterization and sorting, supported by an embedded AI algorithm.
Biolegio offers a range of products, spanning from highly modified and specialised oligos, to standard DNA oligo synthesis.
Applications covered are sequencing, NGS, PCR, Realtime-PCR, SNP detection, genotyping, gene expression and mutation detection.
As the only solution to integrate genotypic and immunophenotypic assessment, the scMRD AML Multiomics Assay targets 40 genes for single-cell DNA sequencing based on current international AML MRD guidelines, such as European LeukemiaNet, and 17-plex antibody-oligonucleotide conjugate (AOC) panel curated for key biomarkers associated with AML MRD.
Through a seamlessly integrated workflow, the assay allows clinician-researchers to:
Laminar Wash technology makes it easy for applications that require a high degree of automation such as screening final product for cell therapeutics. Laminar Wash systems can replace centrifuge integrations and only require one robotic movement instead of over 20 movements. Integration using Laminar Wash technology can:
Superior sensitivity polymerase generating less side products and low copy detection in complex
templates with size up to 6 kb. Highly specific polymerase thanks to efficient blocking at room
temperature. The ALLin™ Buffer includes dNTPs, Magnesium, enhancers, and stabilizers.
10% 2nd Quarter Discount
Celemics Whole Exome Sequencing Panel is the most comprehensive WES panel in the market, covering all target regions of major WES panels in the market.
The panel does not compromise uniformity and performs well against hard-to-capture regions such as GC-rich regions.
The chemiSOLO detects low-expressing proteins with femtogram sensitivity and captures marker images at the push of a button.
A unique web browser interface allows the chemiSOLO to be controlled by phone, tablet, or PC, without the need to install any additional software.
In addition to Western blots, the chemiSOLO captures pictures of colorimetric blots or visible stained protein gels, like Coomassie blue or silver stain.
The chemiSOLO’s wide dynamic range can be further enhanced by using EDR, our Extended Dynamic Range function. This feature allows for linear, quantitative data, while avoiding saturation.
The super compact and intuitive live cell imaging system, Celloger Nano- got everything you need to perform your sophisticate laboratory works. Equipped with exceptional flourescence and auto focusing technology, precise stage controller, and user-friendly software, accelerates your cell-based research works.
The Randox Acusera Serum Indices control is designed to be used to monitor an IVD instrument’s response in the detection of haemolyzed, icteric and lipemic (HIL) samples. This control can be utilised in laboratory interference testing to assist in improving error detection of pre-analytical errors affecting clinical chemistry testing.
This control provides a full range of clinically relevant testing levels, including a negative (-) and three positives (+, ++ & +++)
OZ Biosciences can support every stage of your mRNA-LNP production, from mRNA
synthesis to LNP formulation development, manufacturing and fill & finish.
For any of RNA, DNA or APIs encapsulation, you can provide us with your molecule of
interest and we will formulate it into LNP´s.
Digestif is a universal protein standard to simultaneously assess the quality of sample workup and the performance of your LC-MS system.
Thursday June 6 2024, 5:00 pm (CET)
Despite the richer insights that single-cell multi-omics can offer over conventional techniques such as PCR and bulk next-generation sequencing, including characterizing the clonality of heterogeneous cancer cells and changes driving therapy resistance or assessing genome editing outcomes, the costs for sample analysis can be a barrier to adoption for many labs.
To help address this, Mission Bio has recently launched new sample multiplexing features that allow the pooling of multiple samples into a single run on the Tapestri Platform, improving the throughput and productivity, and thereby reducing the per-sample costs for single-cell DNA and protein multi-omic analysis by up to 60%*.
In this educational webinar, we’ll discuss two novel multiplexing approaches available on Tapestri, Antibody Hashing and Genotype Multiplexing. We’ll explore how they enable increased efficiency and versatility while maintaining the same robust performance metrics such as sensitivity and specificity. We’ll also share real-world case studies from labs that are applying multiplexing approaches in disease modeling, CRISPR-editing, and hemato-oncology applications.
Wednesday May 29 2024, 4:00 pm (CET)
Infant and adult MLL1/KMT2A-rearranged (MLLr) leukemia represents a disease with a dismal prognosis. Here, we characterized early proteomic events of MLL::ENL-mediated transformation in fetal and adult blood progenitors and reveal that whereas adult pre-leukemic cells are mainly characterized by retained myeloid features and downregulation of ribosomal and metabolic proteins, expression of MLL::ENL in fetal lymphomyeloid multipotent progenitors (LMPPs) leads to enrichment of translation-associated and histone deacetylases signaling proteins, and decreased expression of inflammation and myeloid differentiation proteins. Integrating the proteome of pre-leukemic cells with their secretome and the proteomic composition of the extracellular environment of normal progenitors highlights ligand-receptor interactions with differential regulation upon initiation of fetal- and adult-origin leukemia. We show that these interactions have implications for human MLLr leukemia cells’ ability to communicate with their environment through granule proteins. Our study has uncovered opportunities for targeting ontogeny-specific proteomic vulnerabilities in in utero-initiated and adult-onset MLLr leukemia.
Wednesday April 24 2024, 4:00 pm (CET)
Improving coverage, robustness and sensitivity is crucial for routine phosphoproteomics analysis by single-shot liquid chromatography tandem mass spectrometry (LC-MS/MS) from minimal peptide inputs. The presentation focuses on our systematic optimization of key experimental parameters for automated on-beads phosphoproteomics sample preparation with focus on low input samples, pinpointing critical variables influencing the resulting phosphoproteome. Furthermore, we evaluated how sequential enrichment can boost phosphoproteome coverage and show that pooling fractions into a single LC-MS/MS analysis can increase the depth. The presentation also includes an alternative phosphopeptide enrichment strategy based on stepwise addition of beads thereby boosting phosphoproteome coverage. Our optimized phosphoproteomics pipeline can be translated to the newest generation of mass spectrometers, such as the Orbitrap Astral, increasing the phosphopeptide coverage by 2-fold, allowing for deep phosphoproteomics analysis without the need to scale up the starting cell amounts.
Wednesday April 3 2024, 4:00 pm (CET)
Proteins are the primary targets of almost all small molecule drugs. Nonetheless, even drugs designed with high specificity may interact with multiple proteins that are not initially targeted. Discovering these potential interactions is crucial for the development and repurposing of drugs. Current state-of-the-art proteomics methodologies enable screening of thousands of proteins against a limited number of drug molecules. Here we report the development of a label-free quantitative proteomics approach that enables proteome-wide screening of small organic molecules in a scalable, reproducible, and rapid manner by streamlining the proteome integral solubility alteration (PISA) assay.
We understand our customers’ needs and know how to operate flexibly in a quickly changing but always demanding market.
10 000 +
Products
Instruments and reagents based on innovation for improved laboratory methods.
1 000 +
Satisfied Customers
Networking with 1000´s of individual scientists in Denmark, Finland, Norway, Sweden, Iceland and Baltic countries.
20 +
Years Of Experience
We know how to operate flexibly in a quickly changing but always demanding market.
We are looking for enthusiastic sales professionals who enjoy working in the dynamic life science market.
Menu bar
Contact information
Follow us